▶ 調査レポート

世界の5-HT3受容体拮抗薬市場 2021：企業別、地域別、種類・用途別
• 英文タイトル：Global 5-HT3 Receptor Antagonist Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の5-HT3受容体拮抗薬市場 2021：企業別、地域別、種類・用途別 / Global 5-HT3 Receptor Antagonist Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-202A2417資料のイメージです。• レポートコード：GIR-202A2417
• 出版社/出版日：GlobalInfoResearch / 2021年12月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医薬品
• 販売価格（消費税別）
  Single User￥487,200 (USD3,480)▷ お問い合わせ
  Multi User￥730,800 (USD5,220)▷ お問い合わせ
  Corporate User￥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料では、5-HT3受容体拮抗薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。5-HT3受容体拮抗薬の種類別市場規模（オンダンセトロン、グラニセトロン、ドラセトロン、パロノセトロン、その他）、用途別市場規模（病院、クリニック、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・5-HT3受容体拮抗薬の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、GlaxoSmithKline、AstraZeneca、Teva、Takeda Pharmaceutical、Bristol Myers Squibb、Tocris Bioscience、ApexBio、Medochemie、Pfizer、Merck
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：オンダンセトロン、グラニセトロン、ドラセトロン、パロノセトロン、その他
・用途別分析2016年-2026年：病院、クリニック、薬局、その他
・5-HT3受容体拮抗薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・5-HT3受容体拮抗薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・5-HT3受容体拮抗薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・5-HT3受容体拮抗薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・5-HT3受容体拮抗薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The 5-HT3 Receptor Antagonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global 5-HT3 Receptor Antagonist size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global 5-HT3 Receptor Antagonist market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
5-HT3 Receptor Antagonist market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Ondansetron
Granisetron
Dolasetron
Palonosetron
Others

Market segment by Application can be divided into
Hospital
Clinic
Pharmacy
Others

The key market players for global 5-HT3 Receptor Antagonist market are listed below:
Novartis
GlaxoSmithKline
AstraZeneca
Teva
Takeda Pharmaceutical
Bristol Myers Squibb
Tocris Bioscience
ApexBio
Medochemie
Pfizer
Merck

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe 5-HT3 Receptor Antagonist product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of 5-HT3 Receptor Antagonist, with price, sales, revenue and global market share of 5-HT3 Receptor Antagonist from 2019 to 2021.
Chapter 3, the 5-HT3 Receptor Antagonist competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 5-HT3 Receptor Antagonist breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and 5-HT3 Receptor Antagonist market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe 5-HT3 Receptor Antagonist sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 5-HT3 Receptor Antagonist Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global 5-HT3 Receptor Antagonist Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Ondansetron
1.2.3 Granisetron
1.2.4 Dolasetron
1.2.5 Palonosetron
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global 5-HT3 Receptor Antagonist Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Others
1.4 Global 5-HT3 Receptor Antagonist Market Size & Forecast
1.4.1 Global 5-HT3 Receptor Antagonist Sales in Value (2016-2026))
1.4.2 Global 5-HT3 Receptor Antagonist Sales in Volume (2016-2026)
1.4.3 Global 5-HT3 Receptor Antagonist Price by Type (2016-2026) & (US$/Unit)
1.5 Global 5-HT3 Receptor Antagonist Production Capacity Analysis
1.5.1 Global 5-HT3 Receptor Antagonist Total Production Capacity (2016-2026)
1.5.2 Global 5-HT3 Receptor Antagonist Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 5-HT3 Receptor Antagonist Market Drivers
1.6.2 5-HT3 Receptor Antagonist Market Restraints
1.6.3 5-HT3 Receptor Antagonist Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis 5-HT3 Receptor Antagonist Product and Services
2.1.4 Novartis 5-HT3 Receptor Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline 5-HT3 Receptor Antagonist Product and Services
2.2.4 GlaxoSmithKline 5-HT3 Receptor Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca 5-HT3 Receptor Antagonist Product and Services
2.3.4 AstraZeneca 5-HT3 Receptor Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva 5-HT3 Receptor Antagonist Product and Services
2.4.4 Teva 5-HT3 Receptor Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Takeda Pharmaceutical
2.5.1 Takeda Pharmaceutical Details
2.5.2 Takeda Pharmaceutical Major Business
2.5.3 Takeda Pharmaceutical 5-HT3 Receptor Antagonist Product and Services
2.5.4 Takeda Pharmaceutical 5-HT3 Receptor Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Bristol Myers Squibb
2.6.1 Bristol Myers Squibb Details
2.6.2 Bristol Myers Squibb Major Business
2.6.3 Bristol Myers Squibb 5-HT3 Receptor Antagonist Product and Services
2.6.4 Bristol Myers Squibb 5-HT3 Receptor Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Tocris Bioscience
2.7.1 Tocris Bioscience Details
2.7.2 Tocris Bioscience Major Business
2.7.3 Tocris Bioscience 5-HT3 Receptor Antagonist Product and Services
2.7.4 Tocris Bioscience 5-HT3 Receptor Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 ApexBio
2.8.1 ApexBio Details
2.8.2 ApexBio Major Business
2.8.3 ApexBio 5-HT3 Receptor Antagonist Product and Services
2.8.4 ApexBio 5-HT3 Receptor Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Medochemie
2.9.1 Medochemie Details
2.9.2 Medochemie Major Business
2.9.3 Medochemie 5-HT3 Receptor Antagonist Product and Services
2.9.4 Medochemie 5-HT3 Receptor Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer 5-HT3 Receptor Antagonist Product and Services
2.10.4 Pfizer 5-HT3 Receptor Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck 5-HT3 Receptor Antagonist Product and Services
2.11.4 Merck 5-HT3 Receptor Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 5-HT3 Receptor Antagonist Sales by Manufacturer
3.1 Global 5-HT3 Receptor Antagonist Sales in Volume by Manufacturer (2019-2021e)
3.2 Global 5-HT3 Receptor Antagonist Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in 5-HT3 Receptor Antagonist
3.4 Market Concentration Rate
3.4.1 Top 3 5-HT3 Receptor Antagonist Manufacturer Market Share
3.4.2 Top 6 5-HT3 Receptor Antagonist Manufacturer Market Share
3.5 Global 5-HT3 Receptor Antagonist Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and 5-HT3 Receptor Antagonist Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global 5-HT3 Receptor Antagonist Market Size by Region
4.1.1 Global 5-HT3 Receptor Antagonist Sales in Volume by Region (2016-2026)
4.1.2 Global 5-HT3 Receptor Antagonist Revenue by Region (2016-2026)
4.2 North America 5-HT3 Receptor Antagonist Revenue (2016-2026)
4.3 Europe 5-HT3 Receptor Antagonist Revenue (2016-2026)
4.4 Asia-Pacific 5-HT3 Receptor Antagonist Revenue (2016-2026)
4.5 South America 5-HT3 Receptor Antagonist Revenue (2016-2026)
4.6 Middle East and Africa 5-HT3 Receptor Antagonist Revenue (2016-2026)
5 Market Segment by Type
5.1 Global 5-HT3 Receptor Antagonist Sales in Volume by Type (2016-2026)
5.2 Global 5-HT3 Receptor Antagonist Revenue by Type (2016-2026)
5.3 Global 5-HT3 Receptor Antagonist Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global 5-HT3 Receptor Antagonist Sales in Volume by Application (2016-2026)
6.2 Global 5-HT3 Receptor Antagonist Revenue by Application (2016-2026)
6.3 Global 5-HT3 Receptor Antagonist Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America 5-HT3 Receptor Antagonist Sales by Type (2016-2026)
7.2 North America 5-HT3 Receptor Antagonist Sales by Application (2016-2026)
7.3 North America 5-HT3 Receptor Antagonist Market Size by Country
7.3.1 North America 5-HT3 Receptor Antagonist Sales in Volume by Country (2016-2026)
7.3.2 North America 5-HT3 Receptor Antagonist Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe 5-HT3 Receptor Antagonist Sales by Type (2016-2026)
8.2 Europe 5-HT3 Receptor Antagonist Sales by Application (2016-2026)
8.3 Europe 5-HT3 Receptor Antagonist Market Size by Country
8.3.1 Europe 5-HT3 Receptor Antagonist Sales in Volume by Country (2016-2026)
8.3.2 Europe 5-HT3 Receptor Antagonist Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific 5-HT3 Receptor Antagonist Sales by Type (2016-2026)
9.2 Asia-Pacific 5-HT3 Receptor Antagonist Sales by Application (2016-2026)
9.3 Asia-Pacific 5-HT3 Receptor Antagonist Market Size by Region
9.3.1 Asia-Pacific 5-HT3 Receptor Antagonist Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific 5-HT3 Receptor Antagonist Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America 5-HT3 Receptor Antagonist Sales by Type (2016-2026)
10.2 South America 5-HT3 Receptor Antagonist Sales by Application (2016-2026)
10.3 South America 5-HT3 Receptor Antagonist Market Size by Country
10.3.1 South America 5-HT3 Receptor Antagonist Sales in Volume by Country (2016-2026)
10.3.2 South America 5-HT3 Receptor Antagonist Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa 5-HT3 Receptor Antagonist Sales by Type (2016-2026)
11.2 Middle East & Africa 5-HT3 Receptor Antagonist Sales by Application (2016-2026)
11.3 Middle East & Africa 5-HT3 Receptor Antagonist Market Size by Country
11.3.1 Middle East & Africa 5-HT3 Receptor Antagonist Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa 5-HT3 Receptor Antagonist Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 5-HT3 Receptor Antagonist Typical Distributors
12.3 5-HT3 Receptor Antagonist Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global 5-HT3 Receptor Antagonist Revenue by Type, (USD Million), 2021-2026
Table 2. Global 5-HT3 Receptor Antagonist Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis 5-HT3 Receptor Antagonist Product and Services
Table 6. Novartis 5-HT3 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline 5-HT3 Receptor Antagonist Product and Services
Table 10. GlaxoSmithKline 5-HT3 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca 5-HT3 Receptor Antagonist Product and Services
Table 14. AstraZeneca 5-HT3 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Teva Basic Information, Manufacturing Base and Competitors
Table 16. Teva Major Business
Table 17. Teva 5-HT3 Receptor Antagonist Product and Services
Table 18. Teva 5-HT3 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Takeda Pharmaceutical Major Business
Table 21. Takeda Pharmaceutical 5-HT3 Receptor Antagonist Product and Services
Table 22. Takeda Pharmaceutical 5-HT3 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 24. Bristol Myers Squibb Major Business
Table 25. Bristol Myers Squibb 5-HT3 Receptor Antagonist Product and Services
Table 26. Bristol Myers Squibb 5-HT3 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Tocris Bioscience Basic Information, Manufacturing Base and Competitors
Table 28. Tocris Bioscience Major Business
Table 29. Tocris Bioscience 5-HT3 Receptor Antagonist Product and Services
Table 30. Tocris Bioscience 5-HT3 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. ApexBio Basic Information, Manufacturing Base and Competitors
Table 32. ApexBio Major Business
Table 33. ApexBio 5-HT3 Receptor Antagonist Product and Services
Table 34. ApexBio 5-HT3 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Medochemie Basic Information, Manufacturing Base and Competitors
Table 36. Medochemie Major Business
Table 37. Medochemie 5-HT3 Receptor Antagonist Product and Services
Table 38. Medochemie 5-HT3 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Pfizer Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer 5-HT3 Receptor Antagonist Product and Services
Table 42. Pfizer 5-HT3 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Merck Basic Information, Manufacturing Base and Competitors
Table 44. Merck Major Business
Table 45. Merck 5-HT3 Receptor Antagonist Product and Services
Table 46. Merck 5-HT3 Receptor Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global 5-HT3 Receptor Antagonist Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global 5-HT3 Receptor Antagonist Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in 5-HT3 Receptor Antagonist, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global 5-HT3 Receptor Antagonist Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and 5-HT3 Receptor Antagonist Production Site of Key Manufacturer
Table 52. 5-HT3 Receptor Antagonist New Entrant and Capacity Expansion Plans
Table 53. 5-HT3 Receptor Antagonist Mergers & Acquisitions in the Past Five Years
Table 54. Global 5-HT3 Receptor Antagonist Sales by Region (2016-2021e) & (K Units)
Table 55. Global 5-HT3 Receptor Antagonist Sales by Region (2021-2026) & (K Units)
Table 56. Global 5-HT3 Receptor Antagonist Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global 5-HT3 Receptor Antagonist Revenue by Region (2021-2026) & (USD Million)
Table 58. Global 5-HT3 Receptor Antagonist Sales by Type (2016-2021e) & (K Units)
Table 59. Global 5-HT3 Receptor Antagonist Sales by Type (2021-2026) & (K Units)
Table 60. Global 5-HT3 Receptor Antagonist Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global 5-HT3 Receptor Antagonist Revenue by Type (2021-2026) & (USD Million)
Table 62. Global 5-HT3 Receptor Antagonist Price by Type (2016-2021e) & (US$/Unit)
Table 63. Global 5-HT3 Receptor Antagonist Price by Type (2021-2026) & (US$/Unit)
Table 64. Global 5-HT3 Receptor Antagonist Sales by Application (2016-2021e) & (K Units)
Table 65. Global 5-HT3 Receptor Antagonist Sales by Application (2021-2026) & (K Units)
Table 66. Global 5-HT3 Receptor Antagonist Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global 5-HT3 Receptor Antagonist Revenue by Application (2021-2026) & (USD Million)
Table 68. Global 5-HT3 Receptor Antagonist Price by Application (2016-2021e) & (US$/Unit)
Table 69. Global 5-HT3 Receptor Antagonist Price by Application (2021-2026) & (US$/Unit)
Table 70. North America 5-HT3 Receptor Antagonist Sales by Country (2016-2021e) & (K Units)
Table 71. North America 5-HT3 Receptor Antagonist Sales by Country (2021-2026) & (K Units)
Table 72. North America 5-HT3 Receptor Antagonist Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America 5-HT3 Receptor Antagonist Revenue by Country (2021-2026) & (USD Million)
Table 74. North America 5-HT3 Receptor Antagonist Sales by Type (2016-2021e) & (K Units)
Table 75. North America 5-HT3 Receptor Antagonist Sales by Type (2021-2026) & (K Units)
Table 76. North America 5-HT3 Receptor Antagonist Sales by Application (2016-2021e) & (K Units)
Table 77. North America 5-HT3 Receptor Antagonist Sales by Application (2021-2026) & (K Units)
Table 78. Europe 5-HT3 Receptor Antagonist Sales by Country (2016-2021e) & (K Units)
Table 79. Europe 5-HT3 Receptor Antagonist Sales by Country (2021-2026) & (K Units)
Table 80. Europe 5-HT3 Receptor Antagonist Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe 5-HT3 Receptor Antagonist Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe 5-HT3 Receptor Antagonist Sales by Type (2016-2021e) & (K Units)
Table 83. Europe 5-HT3 Receptor Antagonist Sales by Type (2021-2026) & (K Units)
Table 84. Europe 5-HT3 Receptor Antagonist Sales by Application (2016-2021e) & (K Units)
Table 85. Europe 5-HT3 Receptor Antagonist Sales by Application (2021-2026) & (K Units)
Table 86. Asia-Pacific 5-HT3 Receptor Antagonist Sales by Region (2016-2021e) & (K Units)
Table 87. Asia-Pacific 5-HT3 Receptor Antagonist Sales by Region (2021-2026) & (K Units)
Table 88. Asia-Pacific 5-HT3 Receptor Antagonist Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific 5-HT3 Receptor Antagonist Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific 5-HT3 Receptor Antagonist Sales by Type (2016-2021e) & (K Units)
Table 91. Asia-Pacific 5-HT3 Receptor Antagonist Sales by Type (2021-2026) & (K Units)
Table 92. Asia-Pacific 5-HT3 Receptor Antagonist Sales by Application (2016-2021e) & (K Units)
Table 93. Asia-Pacific 5-HT3 Receptor Antagonist Sales by Application (2021-2026) & (K Units)
Table 94. South America 5-HT3 Receptor Antagonist Sales by Country (2016-2021e) & (K Units)
Table 95. South America 5-HT3 Receptor Antagonist Sales by Country (2021-2026) & (K Units)
Table 96. South America 5-HT3 Receptor Antagonist Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America 5-HT3 Receptor Antagonist Revenue by Country (2021-2026) & (USD Million)
Table 98. South America 5-HT3 Receptor Antagonist Sales by Type (2016-2021e) & (K Units)
Table 99. South America 5-HT3 Receptor Antagonist Sales by Type (2021-2026) & (K Units)
Table 100. South America 5-HT3 Receptor Antagonist Sales by Application (2016-2021e) & (K Units)
Table 101. South America 5-HT3 Receptor Antagonist Sales by Application (2021-2026) & (K Units)
Table 102. Middle East & Africa 5-HT3 Receptor Antagonist Sales by Country (2016-2021e) & (K Units)
Table 103. Middle East & Africa 5-HT3 Receptor Antagonist Sales by Country (2021-2026) & (K Units)
Table 104. Middle East & Africa 5-HT3 Receptor Antagonist Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa 5-HT3 Receptor Antagonist Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa 5-HT3 Receptor Antagonist Sales by Type (2016-2021e) & (K Units)
Table 107. Middle East & Africa 5-HT3 Receptor Antagonist Sales by Type (2021-2026) & (K Units)
Table 108. Middle East & Africa 5-HT3 Receptor Antagonist Sales by Application (2016-2021e) & (K Units)
Table 109. Middle East & Africa 5-HT3 Receptor Antagonist Sales by Application (2021-2026) & (K Units)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. 5-HT3 Receptor Antagonist Typical Distributors
Table 113. 5-HT3 Receptor Antagonist Typical Customers
List of Figures
Figure 1. 5-HT3 Receptor Antagonist Picture
Figure 2. Global 5-HT3 Receptor Antagonist Sales Market Share by Type in 2020
Figure 3. Ondansetron
Figure 4. Granisetron
Figure 5. Dolasetron
Figure 6. Palonosetron
Figure 7. Others
Figure 8. Global 5-HT3 Receptor Antagonist Sales Market Share by Application in 2020
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Pharmacy
Figure 12. Others
Figure 13. Global 5-HT3 Receptor Antagonist Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global 5-HT3 Receptor Antagonist Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global 5-HT3 Receptor Antagonist Sales (2016-2026) & (K Units)
Figure 16. Global 5-HT3 Receptor Antagonist Price by Type (2016-2026) & (US$/Unit)
Figure 17. Global 5-HT3 Receptor Antagonist Production Capacity (2016-2026) & (K Units)
Figure 18. Global 5-HT3 Receptor Antagonist Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. 5-HT3 Receptor Antagonist Market Drivers
Figure 20. 5-HT3 Receptor Antagonist Market Restraints
Figure 21. 5-HT3 Receptor Antagonist Market Trends
Figure 22. Global 5-HT3 Receptor Antagonist Sales Market Share by Manufacturer in 2020
Figure 23. Global 5-HT3 Receptor Antagonist Revenue Market Share by Manufacturer in 2020
Figure 24. 5-HT3 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 5-HT3 Receptor Antagonist Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 5-HT3 Receptor Antagonist Manufacturer (Revenue) Market Share in 2020
Figure 27. Global 5-HT3 Receptor Antagonist Sales Market Share by Region (2016-2026)
Figure 28. Global 5-HT3 Receptor Antagonist Revenue Market Share by Region (2016-2026)
Figure 29. North America 5-HT3 Receptor Antagonist Revenue (2016-2026) & (USD Million)
Figure 30. Europe 5-HT3 Receptor Antagonist Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific 5-HT3 Receptor Antagonist Revenue (2016-2026) & (USD Million)
Figure 32. South America 5-HT3 Receptor Antagonist Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa 5-HT3 Receptor Antagonist Revenue (2016-2026) & (USD Million)
Figure 34. Global 5-HT3 Receptor Antagonist Sales Market Share by Type (2016-2026)
Figure 35. Global 5-HT3 Receptor Antagonist Revenue Market Share by Type (2016-2026)
Figure 36. Global 5-HT3 Receptor Antagonist Price by Type (2016-2026) & (US$/Unit)
Figure 37. Global 5-HT3 Receptor Antagonist Sales Market Share by Application (2016-2026)
Figure 38. Global 5-HT3 Receptor Antagonist Revenue Market Share by Application (2016-2026)
Figure 39. Global 5-HT3 Receptor Antagonist Price by Application (2016-2026) & (US$/Unit)
Figure 40. North America 5-HT3 Receptor Antagonist Sales Market Share by Type (2016-2026)
Figure 41. North America 5-HT3 Receptor Antagonist Sales Market Share by Application (2016-2026)
Figure 42. North America 5-HT3 Receptor Antagonist Sales Market Share by Country (2016-2026)
Figure 43. North America 5-HT3 Receptor Antagonist Revenue Market Share by Country (2016-2026)
Figure 44. United States 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe 5-HT3 Receptor Antagonist Sales Market Share by Type (2016-2026)
Figure 48. Europe 5-HT3 Receptor Antagonist Sales Market Share by Application (2016-2026)
Figure 49. Europe 5-HT3 Receptor Antagonist Sales Market Share by Country (2016-2026)
Figure 50. Europe 5-HT3 Receptor Antagonist Revenue Market Share by Country (2016-2026)
Figure 51. Germany 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific 5-HT3 Receptor Antagonist Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific 5-HT3 Receptor Antagonist Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific 5-HT3 Receptor Antagonist Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific 5-HT3 Receptor Antagonist Revenue Market Share by Region (2016-2026)
Figure 60. China 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America 5-HT3 Receptor Antagonist Sales Market Share by Type (2016-2026)
Figure 67. South America 5-HT3 Receptor Antagonist Sales Market Share by Application (2016-2026)
Figure 68. South America 5-HT3 Receptor Antagonist Sales Market Share by Country (2016-2026)
Figure 69. South America 5-HT3 Receptor Antagonist Revenue Market Share by Country (2016-2026)
Figure 70. Brazil 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa 5-HT3 Receptor Antagonist Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa 5-HT3 Receptor Antagonist Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa 5-HT3 Receptor Antagonist Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa 5-HT3 Receptor Antagonist Revenue Market Share by Country (2016-2026)
Figure 76. Turkey 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa 5-HT3 Receptor Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

以下、関連資料のご紹介
  • 世界の5％デキストロース注射市場 2021：企業別、地域別、種類・用途別
    Global 5% Dextrose Injection Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-202A2416 2021年12月 86Pages
    当調査資料では、5％デキストロース注射のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。5％デキストロース注射の種類別市場規模（250 mL、500 mL、1000 mL）、用途別市場規模（応急処置、スポーツ、栄養療法、その他）、地域別市場規模（北米、ア...
  • 世界の5-ニトロイソフタル酸市場 2021：企業別、地域別、種類・用途別
    Global 5-Nitroisophthalic Acid Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-202A0628 2021年12月 104Pages
    当調査資料では、5-ニトロイソフタル酸のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。5-ニトロイソフタル酸の種類別市場規模（純度98％、純度99％、その他）、用途別市場規模（染料中間体、医薬品中間体、農薬中間体、その他）、地域別市場規模（北米、アメリ...
  • 世界の5,6,7,8-テトラヒドロキノリン試薬市場 2021：企業別、地域別、種類・用途別
    Global 5,6,7,8-Tetrahydroquinoline Reagent (CAS 10500-57-9) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-202A0607 2021年12月 95Pages
    当調査資料では、5,6,7,8-テトラヒドロキノリン試薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。5,6,7,8-テトラヒドロキノリン試薬の種類別市場規模（≥99％、98％-99％、95％-98％、その他）、用途別市場規模（抗生物質、その他）、地...
  • 世界の5-アミノ-6-クロロ-o-クレゾール市場 2021：企業別、地域別、種類・用途別
    Global 5-Amino-6-Chloro-o-Cresol Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-202A0611 2021年12月 79Pages
    当調査資料では、5-アミノ-6-クロロ-o-クレゾールのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。5-アミノ-6-クロロ-o-クレゾールの種類別市場規模（98〜99％、99％以上）、用途別市場規模（スキンケア製品、ヘアケア製品、化粧品、その他）、地...
  • 世界の5-シアノインドール市場 2021：企業別、地域別、種類・用途別
    Global 5-Cyanoindole Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-202A0619 2021年12月 98Pages
    当調査資料では、5-シアノインドールのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。5-シアノインドールの種類別市場規模（純度98％、純度99％、その他）、用途別市場規模（医薬品中間体、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国...
  • 世界の5-アミノ-4,6-ジクロロピリミジン市場 2021：企業別、地域別、種類・用途別
    Global 5-Amino-4,6-Dichloropyrimidine (CAS 5413-85-4) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-202A0610 2021年12月 104Pages
    当調査資料では、5-アミノ-4,6-ジクロロピリミジンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。5-アミノ-4,6-ジクロロピリミジンの種類別市場規模（純度97％、純度98％、純度99％、その他）、用途別市場規模（化学工業、医薬品、その他）、地域...
  • 世界の5-クロロサリチルアルデヒド市場 2021：企業別、地域別、種類・用途別
    Global 5-Chlorosalicylaldehyd Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-202A0617 2021年12月 84Pages
    当調査資料では、5-クロロサリチルアルデヒドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。5-クロロサリチルアルデヒドの種類別市場規模（98％純度、99％純度）、用途別市場規模（製薬産業、香辛料産業、染料産業、有機合成、その他）、地域別市場規模（北米...
  • 世界の5〜20MWガスタービン市場 2021：企業別、地域別、種類・用途別
    Global 5-20MW Gas Turbine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-202A1648 2021年12月 92Pages
    当調査資料では、5〜20MWガスタービンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。5〜20MWガスタービンの種類別市場規模（5-10MWガスタービン、10-20MWガスタービン）、用途別市場規模（土地発電、石油・ガス）、地域別市場規模（北米、アメ...
  • 世界の5-クロロチオフェン-2-塩化カルボニル市場 2021：企業別、地域別、種類・用途別
    Global 5-Chorothiophene-2-Carbonyl Chloride (CAS 42518-98-9) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-202A0618 2021年12月 103Pages
    当調査資料では、5-クロロチオフェン-2-塩化カルボニルのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。5-クロロチオフェン-2-塩化カルボニルの種類別市場規模（純度97％、純度98％、純度99％、その他）、用途別市場規模（工業、研究所、その他）、地域...
  • 世界の5-ブロモインドール-2-カルボン酸エチルエステル市場 2021：企業別、地域別、種類・用途別
    Global 5-Bromoindole-2-Carboxylic Acid Ethyl Ester (CAS 16732-70-0) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-202A0613 2021年12月 98Pages
    当調査資料では、5-ブロモインドール-2-カルボン酸エチルエステルのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。5-ブロモインドール-2-カルボン酸エチルエステルの種類別市場規模（純度97％、純度98％、純度99％、その他）、用途別市場規模（工業、研...